What the research says regarding this treatment combination
Many women navigating menopause experience disruptive symptoms and hormonal shifts. Hormone replacement therapy (HRT) has long been a go-to treatment, but with the rise of GLP-1 medications for weight management, some are wondering—can these two therapies be combined? Let’s explore what the research says about using HRT and GLP-1s together for menopause symptom relief.
What is menopause?
Menopause is a natural stage in a woman’s life that marks the end of her reproductive years, typically occurring between the ages of 45 and 55. It is officially diagnosed after 12 consecutive months without a menstrual period, signaling a significant decline in estrogen and progesterone production by the ovaries.
This hormonal shift can bring a range of symptoms, including hot flashes, night sweats, mood changes, and weight gain, which vary in severity from person to person. While menopause itself is not a medical condition, its effects on the body can impact overall health and quality of life, leading many women to explore treatment options such as hormone replacement therapy (HRT) and lifestyle modifications.
Menopause symptoms and how HRT and GLP-1s might help
HRT works by supplementing estrogen and progesterone to help rebalance hormone levels affected by menopause. More recently, a newer class of medications known as GLP-1 receptor agonists (GLP-1s) has gained attention. Originally developed for type 2 diabetes and weight loss, GLP-1s are now being explored for their potential benefits in managing menopause symptoms. But can HRT and GLP-1s be safely combined? Let’s dive into the science behind this important question.
Understanding HRT and GLP-1s
HRT involves the use of synthetic hormones, usually estrogen and progesterone. HRT can help with many of the most common symptoms of menopause like hot flashes and night sweats, and can also reduce the risk of osteoporosis (bone loss). However, HRT isn’t the best choice for everyone, especially if you have a history of certain cancers or blood clots. For this reason, many women are seeking out alternatives or complementary therapies.
GLP-1 receptor agonists, such as semaglutide, are mostly used to manage type 2 diabetes and obesity (weight loss). GLP-1 drugs copy the naturally occurring hormone in your body called glucagon-like peptide 1 (GLP-1), which helps regulate your blood sugar levels and lower your appetite by slowing the speed at which your stomach empties itself keeping you feeling fuller longer. Because of GLP-1s weight loss effects, and since weight gain during menopause is common due to changes in metabolism and hormonal shifts, many people with menopausal weight gain could potentially benefit from these medications.
The potential benefits of combining HRT with GLP-1s
One of the main reasons that women are considering the combination of HRT plus GLP-1s is the potential for enhanced menopause symptom relief including weight loss. GLP-1s have been shown to help reduce appetite and promote weight loss, a symptom many women encounter during and after menopause, the addition of a GLP-1 to a menopausal woman’s medication regimen could be of benefit.
Weight gain during menopause isn’t just about body image, weight gain can contribute to a plethora of other issues like increased risk of heart and vascular disease, type 2 diabetes, joint problems, and fatty liver disease (NAFLD).
Since HRT has the potential to cause weight gain as a side effect, pairing it with a GLP-1 receptor agonist may help offset this weight gain.
Another interesting finding is that GLP-1s have been shown to have anti-inflammatory properties and may improve insulin sensitivity, which could have broader health benefits for menopausal women.
This combo of a GLP-1s ability to manage body weight, lower blood sugar levels and reduce inflammation, along with HRT’s effects on hormone balancing, could provide a more complete approach to managing the various menopause-related health issues and symptoms .
What the research says
While the idea of combining HRT and GLP-1s sounds very promising, scientific research on their combined use in menopausal women is still in very early stages. Studies on GLP-1s for menopause-related symptoms are few, and most of the available evidence comes from research focusing on the effects of GLP-1s in other groups of people, like people with diabetes or obesity.
That being said, there is some emerging evidence that GLP-1s can help with weight management, and when combined with HRT, the two may offer a dual and partially overlapping approach to managing a broader range of symptoms like weight gain, hot flashes, and mood swings.
A recent study showed that women on the combination of GLP-1 and HRT lost more weight than those only on GLP-1.
Another study also showed that naturally occurring GLP-1 levels in the blood in adult women correlated with metabolic syndrome (a cluster of health abnormalities that cause chronic health problems like heart disease). This suggests that adding a GLP-1 to a woman’s medication regimen could help reduce their risk of metabolic syndrome.
Another promising study showed that there is likely a synergistic effect between hormone replacement and GLP-1s in treating obesity and type 2 diabetes in menopausal women.
Safety considerations and potential risks
As with taking any medication, the combination of HRT and GLP-1s should be considered carefully under the guidance of a healthcare professional.
Both HRT and GLP-1 receptor agonists come with their own set of side effects and potential risks. HRT can increase the risk of blood clots, stroke, and certain types of cancer, particularly if used long-term or in women with pre-existing health conditions. And while GLP-1s are generally very well tolerated, they can cause side effects like nausea, diarrhea, and potential gastrointestinal issues.
Whenever you are considering a medication combination, it’s essential to consult with a healthcare professional who can assess your individual risk factors, medical and family history, and other medications you take to decide if this combination is safe for you. For example, since GLP-1s can lower your blood sugar, if you are already on other diabetes medications you might need to adjust their doses down or stop them to prevent low blood sugar episodes (hypoglycemia).
HRT and GLP-1 combination for menopausal women
Combining hormone replacement therapy with GLP-1s for women in menopause is still in its early stages. More research is needed to fully understand the benefits and risks of this combination. As of now, evidence suggests that GLP-1s may help manage weight gain and improve metabolic health in menopausal women, making them a promising new complementary treatment alongside HRT if approved by a healthcare professional.
The decision to combine HRT with GLP-1s has to be tailored to each woman’s individual medical circumstances, symptoms, and other health risks. With careful management and professional insight, these two therapies combined might offer a more thorough solution to managing the various challenges that come with menopause.
Access better wellness for your employees with Agile Telehealth
At Agile, we provide employers with the opportunity to implement top-tier wellness programs for their teams—at little to no cost. How do we do it? By leveraging our extensive network of board-certified physicians and trusted pharmacy partners, we’re able to deliver customized wellness solutions and personalized compounded medications, like GIP, at a fraction of the cost of traditional benefits programs.
Interested in learning more? Contact us here!
Browse our list of available programs!